Provided by Tiger Trade Technology Pte. Ltd.

Pampa Energia SA

87.23
-1.1700-1.32%
Post-market: 87.230.00000.00%16:10 EST
Volume:131.92K
Turnover:11.65M
Market Cap:4.74B
PE:14.74
High:90.02
Open:89.84
Low:87.00
Close:88.40
52wk High:97.55
52wk Low:54.95
Shares:54.39M
Float Shares:27.04M
Volume Ratio:1.08
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.92
EPS(LYR):11.38
ROE:9.71%
ROA:2.36%
PB:1.48
PE(LYR):7.67

Loading ...

Press Release: Saviynt Raises $700M at Approximately $3B Valuation in KKR-Led Round to Establish Identity Security as the Foundation for the AI Era

Dow Jones
·
Dec 09

Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium

GlobeNewswire
·
Nov 27

Nyse Order Imbalance 17128.0 Shares on Sell Side

THOMSON REUTERS
·
Nov 25

ASEAN's Leading Architects Convene in Jakarta For An Inspirational Symposium: 'Shaping Resilient Future: Heritage and Modernity in Steel Architectural Design'

prnewswire
·
Nov 10

Press Release: Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Dow Jones
·
Nov 06

Earnings Flash (PAM) Pampa Energia Posts Q3 Net Income Per ADR of $0.40, vs. FactSet Est of $0.73 By Single Analyst

MT Newswires Live
·
Nov 05

Pampa Energia Q3 EPS $0.40 Misses $1.61 Estimate, Sales $591.000M Miss $510.491B Estimate

Benzinga
·
Nov 05

Pampa Energia Shares Rise After Citigroup Upgrade

MT Newswires Live
·
Nov 04

Citigroup Upgrades Pampa Energia to Buy From Neutral, Adjusts Price Target to $113 From $92

MT Newswires Live
·
Nov 03

Pampa Energia upgraded to Buy from Neutral at Citi

TIPRANKS
·
Nov 01

Pampa Energia SA expected to post earnings of $1.75 a share - Earnings Preview

Reuters
·
Nov 01

Pampa Energia Up Nearly 26%, on Pace for Record Percent Increase -- Data Talk

Dow Jones
·
Oct 28

Argentina's Midterm Election Hands Decisive Win to Milei's Libertarian Overhaul

Reuters
·
Oct 27

BUZZ-Argentina ADRs rally after President Javier Milei's party wins midterm elections

Reuters
·
Oct 27

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

GlobeNewswire
·
Oct 21

Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer

GlobeNewswire
·
Oct 18

Prediction: While Nvidia Leads, This Lesser-Known AI Stock Could Catch Up

Motley Fool
·
Oct 09

Press Release: Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

Dow Jones
·
Sep 30

BUZZ-US-listed Argentine shares rally after US pledges support

Reuters
·
Sep 24

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

GlobeNewswire
·
Sep 18